This is a synthetic peptide designed for use in combination with anti-PEA15 Antibody(ARP58923_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
PEA15
Reaktivität: Human, Maus, Ratte, Affe
Wirt: Synthetic
BP
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
PEA15
(phosphoprotein Enriched in Astrocytes 15 (PEA15))
Synonyme
HMAT1 Peptide, HUMMAT1H Peptide, MAT1 Peptide, MAT1H Peptide, PEA-15 Peptide, PED Peptide, Pea15a Peptide, PEA15 Peptide, DKFZp459O1410 Peptide, proliferation and apoptosis adaptor protein 15 Peptide, phosphoprotein enriched in astrocytes 15 Peptide, proliferation and apoptosis adaptor protein 15 L homeolog Peptide, Astrocytic phosphoprotein PEA-15 Peptide, PEA15 Peptide, Pea15 Peptide, pea15.L Peptide, pea15 Peptide
Hintergrund
PEA15 is a death effector domain (DED)-containing protein predominantly expressed in the central nervous system, particularly in astrocytes.
Alias Symbols: HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED
Protein Interaction Partner: AKT1,MAPK3,RPS6KA3,ABCD4,AKD1,AKT1,CAMK2G,CASP8,FADD,HTRA2,L1CAM,LUC7L2,MAPK1,MAPK3,PANK4,PLD1,PLD2,PRKCA,RPS6KA3,ABCD4,CASP8,FADD,Gm899,L1CAM,LUC7L2,MAPK1,MAPK3,PLD1,PLD2,RPS6KA3